STEPHANIE WESTON: Open Payments
NPI 1043709736 · YPSILANTI, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$353 in 16 payments from 8 companies in 2025. Trend: 2023 $285 · 2024 $251 · 2025 $353
Food & beverage: $353
| Company | Payments | Amount |
|---|---|---|
| Travere Therapeutics, Inc. | 5 | $94 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $55 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $46 |
| GlaxoSmithKline, LLC. | 2 | $43 |
| Vifor Pharma, Inc. | 2 | $40 |
| Calliditas Therapeutics US Inc. | 1 | $35 |
| Fresenius USA Marketing, Inc. | 1 | $24 |
| Amgen Inc. | 1 | $16 |
Products named: Kerendia, JARDIANCE, BENLYSTA, Veltassa, TARPEYO, VELPHORO, TAVNEOS.
Industry payments across MI — which companies pay providers there.
